01 January 2018

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

01 January 2018 | n=48

  1. Rubinstein PG, Moore PC, Rudek MA, Henry DH, et al.
    Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma.
    AIDS 2017.

  2. Rodriguez-Gallego E, Gomez J, Pacheco YM, Peraire J, et al.
    A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of ART in HIV-infected patients.
    AIDS 2017.

  3. Nicoli F, Gallerani E, Sforza F, Finessi V, et al.
    The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naive CD4+ T cells.
    AIDS 2017.

  4. Abecasis AB, Pingarilho M, Vandamme AM.
    Phylogenetic analysis as a forensic tool in HIV transmission investigations: a literature review.
    AIDS 2017.

  5. Geffner ME, Patel K, Jacobson DL, Wu J, et al.
    Changes in Insulin Sensitivity over Time and Associated Factors in HIV-Infected Adolescents.
    AIDS 2017.

  6. Luo M, Czarnecki C, Nebroski M, Kimani J, et al.
    KIR3DL1 alleles and their Epistatic Interactions with HLA Class I Influence Resistance and Susceptibility to HIV-1 acquisition in the Pumwani Sex Worker cohort.
    AIDS 2017.

  7. Kojima N, Klausner JD.
    Improving management of sexually transmitted infections in those who use pre-exposure prophylaxis for human immunodeficiency virus infection.
    AIDS 2018;32:272-275.

  8. Arranz-Caso A, Perez-Cruz F, Villa A, Sanz J, et al.
    Kaposi sarcoma presenting shortly after primary infection by HIV and human herpesvirus-8.
    AIDS 2018;32:271-275.

  9. Ringel O, Muller K, Koch J, Brill B, et al.
    Optimization of the EC26-2A4 epitope in the gp41 membrane proximal external region (MPER) targeted by neutralizing antibodies from an elite controller.
    AIDS Res Hum Retroviruses 2017.

  10. Volk JE, Nguyen DP, Hare CB, Marcus JL, et al.
    HIV Infection and Drug Resistance with Unsupervised Use of HIV Preexposure Prophylaxis.
    AIDS Res Hum Retroviruses 2017.

  11. Bakshi RP, Breakey JC, Manohar M, Jois B, et al.
    Specimen Processing Impacts Tissue Tenofovir PK Measurements.
    AIDS Res Hum Retroviruses 2017.

  12. Cerejo P, Santos-Costa Q, Calado M, Espirito-Santo M, et al.
    Characterization of Env surface glycoprotein from HIV-2 primary isolates with different coreceptor usage profile.
    AIDS Res Hum Retroviruses 2017.

  13. Alexiev I, Lo Presti A, Dimitrova R, Foley BT, et al.
    Origin and Spread of HIV-1 Subtype B among Heterosexual Individuals in Bulgaria.
    AIDS Res Hum Retroviruses 2017.

  14. Miao J, Ran J, Song Y, Liu Y, et al.
    Characterization of a Novel HIV-1 Circulating Recombinant Form, CRF01_AE/B'/C (CRF96_cpx), in Yunnan, China.
    AIDS Res Hum Retroviruses 2017.

  15. Brown TR.
    Timothy Ray Brown's Continuing Activism Toward Curing HIV.
    AIDS Res Hum Retroviruses 2017.

  16. Weiser J, Perez A, Bradley H, King H, et al.
    Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012.
    Ann Intern Med 2017.

  17. Hua S, Vigano S, Tse S, Zhengyu O, et al.
    Pegylated IFN-alpha-induced NK cell activation is associated with HIV-1 DNA decline in ART-treated HIV-1/HCV co-infected patients.
    Clin Infect Dis 2017.

  18. Arikawa S, Rollins N, Jourdain G, Humphrey J, et al.
    Contribution of maternal ART and breastfeeding to 24-month survival in HIV-exposed uninfected children: an individual pooled analysis of African and Asian studies.
    Clin Infect Dis 2017.

  19. Unal G, Alessandri-Gradt E, Leoz M, Pavie J, et al.
    HIV-1 group O infection in France: clinical features and immunovirological response to antiretrovirals.
    Clin Infect Dis 2017.

  20. Greene SA, McGrath CJ, Lehman DA, Marson KG, et al.
    Increased Cervical HIV RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure (LEEP) compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3.
    Clin Infect Dis 2017.

  21. Yeganeh N, Kerin T, Ank B, Watts H, et al.
    HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.
    Clin Infect Dis 2017.

  22. Stockdale AJ, Saunders MJ, Boyd MA, Bonnett LJ, et al.
    Effectiveness of protease inhibitor/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of HIV-1 infection in sub-Saharan Africa: systematic review and meta-analysis.
    Clin Infect Dis 2017.

  23. Taiwo BO, Zheng L, Stefanescu A, Nyaku A, et al.
    ACTG A5353: A pilot study of dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA < 500,000 copies/mL.
    Clin Infect Dis 2017.

  24. Madhi SA, Cutland CL, Downs S, Jones S, et al.
    Burden of respiratory syncytial virus infection in South African HIV-infected and HIV-uninfected pregnant and post-partum women: A longitudinal cohort study.
    Clin Infect Dis 2017.

  25. Knettel BA, Cichowitz C, Ngocho JS, Knippler ET, et al.
    Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: A Systematic Review and Meta-Analysis of Studies in Africa.
    J Acquir Immune Defic Syndr 2017.

  26. Benhammou V, Tubiana R, Matheron S, Sellier P, et al.
    Hbv or Hcv Coinfection in Hiv-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
    J Acquir Immune Defic Syndr 2017.

  27. Wagner AD, O'malley G, Firdawsi O, Mugo C, et al.
    Disclosure, consent, opportunity costs, and inaccurate risk assessment deter pediatric HIV testing: a mixed-methods study.
    J Acquir Immune Defic Syndr 2017.

  28. Stekler JD, Mcmahan V, Ballinger L, Viquez L, et al.
    HIV Pre-exposure Prophylaxis (PrEP) Prescribing Through Telehealth.
    J Acquir Immune Defic Syndr 2017.

  29. Janulis P, Phillips G 2nd, Birkett M, Mustanski B, et al.
    Sexual Networks of Racially Diverse Young Msm Differ in Racial Homophily But not Concurrency.
    J Acquir Immune Defic Syndr 2017.

  30. Dorward J, Yende-Zuma N, Samsunder N, Karim QA, et al.
    Clinic-Based Evaluation of A Point-Of-Care Creatinine Assay to Screen for Renal Impairment Amongst Hiv-Positive Patients Receiving Tenofovir Disoproxil Fumarate.
    J Acquir Immune Defic Syndr 2017.

  31. Patel MR, Foote C, Duwve J, Chapman E, et al.
    Reduction of Injection-Related Risk Behaviors Following Emergency Implementation of A Syringe Services Program During an Hiv Outbreak.
    J Acquir Immune Defic Syndr 2017.

  32. Gibbs A, Buggert M, Edfeldt G, Ranefall P, et al.
    HIV-infected women have high numbers of CD103-CD8+ T cells residing close to the basal membrane of the ectocervical epithelium.
    J Infect Dis 2017.

  33. Shiels MS, Kirk GD, Drummond MB, Dhillon D, et al.
    HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.
    J Infect Dis 2017.

  34. Wallender E, Vucicevic K, Jagannathan P, Huang L, et al.
    Predicting optimal dihydroartemisinin-piperaquine regimens to prevent malaria during pregnancy for HIV-infected women receiving efavirenz.
    J Infect Dis 2017.

  35. Boppana SB, Britt WJ, Fowler K, Hutto SC, et al.
    Pathogenesis of Non-Zika Congenital Viral Infections.
    J Infect Dis 2017;216:S912-S918.

  36. Gregory CJ, Oduyebo T, Brault AC, Brooks JT, et al.
    Modes of Transmission of Zika Virus.
    J Infect Dis 2017;216:S875-S883.

  37. Gallant J, Hsue PY, Shreay S, Meyer N, et al.
    Comorbidities Among US Patients With Prevalent HIV Infection-A Trend Analysis.
    J Infect Dis 2017;216:1525-1533.

  38. van der Valk M, Reiss P.
    Noncommunicable Diseases in People Living With HIV: Time for Integrated Care.
    J Infect Dis 2017;216:1481-1483.

  39. Gu Q, Zhang Z, Gertzen CGW, Haussinger D, et al.
    Identification of a conserved interface of HIV-1 and FIV Vifs with Cullin 5.
    J Virol 2017.

  40. Zhou R, Wang X, Liu H, Guo L, et al.
    GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors.
    J Virol 2017.

  41. Liang R, Sun Y, Liu Y, Wang J, et al.
    Major histocompatibility complex class I (FLA-E*01801) molecular structure in domestic cats demonstrates species-specific characteristics in presenting viral antigen peptides.
    J Virol 2017.

  42. Charan J, Goyal JP, Reljic T, Emmanuel P, et al.
    Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis.
    Pediatr Infect Dis J 2017.

  43. Rice ML, Russell JS, Frederick T, Purswani M, et al.
    Risk for Speech and Language Impairments in Pre-school Aged HIV-Exposed Uninfected Children with in utero Combination Antiretroviral Exposure.
    Pediatr Infect Dis J 2017.

  44. Brophy J, Bitnun A, Alimenti A, Lapointe N, et al.
    Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living with HIV.
    Pediatr Infect Dis J 2017.

  45. Belard S, Heuvelings CC, Banderker E, Bateman L, et al.
    Utility of Point-of-Care Ultrasound in Children with Pulmonary Tuberculosis.
    Pediatr Infect Dis J 2017.

  46. Yasen A, Herrera R, Rosbe K, Lien K, et al.
    HIV internalization into oral and genital epithelial cells by endocytosis and macropinocytosis leads to viral sequestration in the vesicles.
    Virology 2017;515:92-107.

  47. Schulte B, Selyutina A, Opp S, Herschhorn A, et al.
    Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.
    Virology 2017;515:52-65.

  48. Prevost J, Richard J, Ding S, Pacheco B, et al.
    Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals.
    Virology 2017;515:38-45.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

21 January 2019

14 January 2019

07 January 2019

30 December 2018

23 December 2018

01 January 2018

Multidisciplinary Journal Club

  1. Katz J, Englund JA, Steinhoff MC, Khatry SK, et al.
    Nutritional status of infants at six months of age following maternal influenza immunization: A randomized placebo-controlled trial in rural Nepal.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31372.

  2. Connors JM, Jurczak W, Straus DJ, Ansell SM, et al.
    Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2017 Dec 10. doi: 10.1056/NEJMoa1708984.

  3. Harms MH, Lammers WJ, Thorburn D, Corpechot C, et al.
    Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
    Am J Gastroenterol. 2017 Dec 12. pii: ajg2017440. doi: 10.1038/ajg.2017.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016